About Maha Katabi
Form D filings for Marea Therapeutics in 2024 list Maha Katabi as director.
Form D filings also name Maha Katabi as a director at Quanta Therapeutics.
Maha Katabi reports to the SEC as a director or major shareholder of 7 public companies, including Vera Therapeutics (VERA), Jade Biosciences (JBIO) and RayzeBio (RYZB).
Maha Katabi first appears on SEC filings in 2020.
Experience
This experience comes from Maha Katabi's profile and from SEC filings. For roles taken from filings, the years are when the filings name Maha Katabi in the role, so the role may have started earlier or lasted longer.
CB
Coultreon Biopharma Current
Board Member
2026 – Present
AR
ARTBIO Current
Board Member
2025 – Present
ST
Star Therapeutics Current
Board Member
2023 – Present
Quanta Therapeutics, Inc. Current
Director
2021 – Present · South San Francisco, CA
Develops cancer medicines for patients with RAS-driven cancers.
SI
Sofinnova Investments Current
General Partner
2019 – Present
VI
Vera Therapeutics, Inc.
Director and 10% owner
2020 – 2026 · Public company (VERA)
EI
Exactis Innovation
Chair of the Board of Directors
2019 – 2025
JI
Jade Biosciences, Inc.
Director and 10% owner
2021 – 2024 · Public company (JBIO)
RI
RayzeBio, Inc.
Director
2022 – 2024 · Public company (RYZB)
AB
Aiolos Bio
Board Member
2023 – 2024
AI
Aerovate Therapeutics, Inc.
Board Member
2020 – 2024
CI
CinCor Pharma, Inc.
10% owner
2022 – 2023 · Public company (CINC)
GT
GYROSCOPE Tx
Board Member
2021 – 2022
NT
NorthSea Therapeutics
Board Member
2019 – 2022
BI
Bolt Biotherapeutics, Inc.
10% owner
2021 · Public company (BOLT)
AI
Amplyx Pharmaceuticals, Inc
Board Member
2020 – 2021
II
Inozyme Pharma, Inc.
10% owner
2020 · Public company (INZY)
AI
Akouos, Inc.
10% owner
2020 · Public company (AKUS)
OC
Oxalis Capital
Managing Partner
2018 – 2019
SM
Sectoral Asset Management
Partner, Private Equity
2008 – 2018
AP
Apellis Pharmaceuticals
Board Member
2017
VW
Ventures West
Vice-President
2004 – 2008
TC
T2C2 Capital
Associate
1999 – 2002
Key Colleagues at Startups
The people Maha Katabi works with at each company, as listed on that company's latest Form D.
Quanta Therapeutics, Inc. · Form D/A, Jun 24, 2026
PN
Perry Nisen
Chief Executive Officer and director
CP
Cameron Pitt
Chief Operating Officer and director
MF
Maria Fardis
Director
YH
Ying Huang
Director
DM
Derek Metzger
Chief Strategy Officer
RJ
Rajul Jain
Director
Marea Therapeutics, Inc. · Form D, Jun 24, 2024
MJ
Mark Joing
Executive officer
JT
Jeff Tong
Director
CG
Christine Garrett
Executive officer
JL
Josh Lehrer
Chief Executive Officer and President, director
EW
Ethan Weiss
Executive officer
AR
Aaron Royston
Director
CM
Caitlin Murray
Executive officer
JC
Jung Choi
Director
TL
Ted Love
Director
AB
Antoine Boulanger
Director
CG
Chris Garabedian
Director